INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 444m ago
House PTR44m ago
SEC 13F43m ago
Robinhood Chain43m ago

Most active filers · 30d

  1. 01FWFogarty Patrick W0B / 206S206 trades$1.10M
  2. 02Kurtz George0B / 202S202 trades$48.06M
  3. 03SPSaba Capital Management, L.P.67B / 19S · 11 late86 trades$21.51M
  4. 04NYNissan Yitzhak82B / 0S · 79 late82 trades$2.61M
  5. 05ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  6. 06AJAllaire Jeremy0B / 50S50 trades$4.26M
  7. 07Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  8. 08SJSheena Jonathan0B / 45S45 trades$3.01M
  9. 09SISarowitz Steven I2B / 34S36 trades$21.18M
  10. 10SLSpeiser Michael L0B / 35S35 trades$14.00M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 1732 insiders$917K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 179 insiders$893K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 168 insiders$42.58M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLMGNIMAGNITE, INC.Nov 5 – Nov 178 insiders$2.77M
  7. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  8. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M

Form 4 transactions

73,372 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
4
Dines DanielDirector, CEO and Chairman, 10% Owner
PATHUiPath, Inc.
Open-market sale · 10b5-1 plan
SELL$676K
45.0K sh
Jan 22, 2026
Page 1452 of 1835
← PrevNext →
Jan 26, 2026
traded Jan 22, 2026
+4d
SEC Form 4

Evidence

3
BA
Bachrodt AmySVP, Finance
MAZEMaze Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
2,503 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

3
Farquhar ScottDirector, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$13K
100 sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence

3
KN
Kroeker NathanCCO and Interim CFO
EOSEEos Energy Enterprises, Inc.
Option exercise · 10b5-1 plan
M—
100.0K sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence

3
CM
Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$13K
100 sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence

2
KA
Kussell William ADirector
FWRGFirst Watch Restaurant Group, Inc.
Option exercise · 10b5-1 plan
M$52K
6,165 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

2
FS
Frazier SpencerEVP of Sales and Marketing
JBHTHUNT J B TRANSPORT SERVICES INC
Grant or award
A—
1,060 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

2
FS
Frazier SpencerEVP of Sales and Marketing
JBHTHUNT J B TRANSPORT SERVICES INC
Grant or award
A—
1,591 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

2
GE
Gilliam Joseph EPRESIDENT & COO
GKOSGLAUKOS Corp
Option exercise · 10b5-1 plan
M$171K
3,100 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

0
SB
Slowe Christopher BrianChief Technology Officer
RDDTReddit, Inc.
Derivative conversion · 10b5-1 plan
C—
12.0K sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

0
BH
Beckwith Van H.EVP, Secretary and CLO
HALHALLIBURTON CO
Option exercise · 10b5-1 plan
M—
54.3K sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence

0
SB
Slowe Christopher BrianChief Technology Officer
RDDTReddit, Inc.
Option exercise · 10b5-1 plan
M—
12.0K sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

0
KN
Kroeker NathanCCO and Interim CFO
EOSEEos Energy Enterprises, Inc.
Option exercise · 10b5-1 plan
M—
100.0K sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence

0
SB
Slowe Christopher BrianChief Technology Officer
RDDTReddit, Inc.
Derivative conversion · 10b5-1 plan
C—
12.0K sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

0
BA
Bachrodt AmySVP, Finance
MAZEMaze Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
2,497 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

0
HI
Hyep IvanChief Financial Officer
BCAXBicara Therapeutics Inc.
Option exercise · 10b5-1 plan
M$7,132
1,882 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

0
HI
Hyep IvanChief Financial Officer
BCAXBicara Therapeutics Inc.
Option exercise · 10b5-1 plan
M—
1,882 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

0
BA
Bachrodt AmySVP, Finance
MAZEMaze Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$26K
2,497 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

0
BA
Bachrodt AmySVP, Finance
MAZEMaze Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$26K
2,503 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

0
SB
Slowe Christopher BrianChief Technology Officer
RDDTReddit, Inc.
Option exercise · 10b5-1 plan
M—
12.0K sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

0
OP
O'Day Daniel PatrickDirector, Chairman & CEO
GILDGILEAD SCIENCES, INC.
Option exercise · 10b5-1 plan
M—
115.6K sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence

70
NR
Nielson Brandon R.Director
NANAKeystone Private Income Fund
Open-market purchase
BUY$2.00M
20.3K sh
Jan 1, 2026Jan 23, 2026
traded Jan 1, 2026
+22dSEC Form 4

Evidence

63
EJ
Earl JohnPresident
NANAKeystone Private Income Fund
Open-market purchase
BUY$1000K
10.1K sh
Jan 1, 2026Jan 23, 2026
traded Jan 1, 2026
+22dSEC Form 4

Evidence

61
AJ
Agarwal A.J.Director, Co-President
NONENONEBlackstone Real Estate Income Trust, Inc.
Open-market purchase
BUY$4.00M
287.3K sh
Dec 1, 2025Jan 23, 2026
traded Dec 1, 2025
+53dSEC Form 4

Evidence

58
AB
Allen BradTreasurer
NANAKeystone Private Income Fund
Open-market purchase
BUY$1.00M
10.1K sh
Jan 1, 2026Jan 23, 2026
traded Jan 1, 2026
+22dSEC Form 4

Evidence

46
KR
Kushel J. RichardSenior Managing Director
BLKBlackRock, Inc.
Open-market sale
SELL$22.50M
20.0K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

45
CM
Carr James McgregorExecutive Vice Pres.
CMACOMERICA INC
Open-market sale
SELL$981K
10.0K sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

45
WH
Weber James HarryExecutive Vice President
CMACOMERICA INC
Open-market sale
SELL$863K
8,798 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

44
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$1.03M
10.8K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

44
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$8.12M
87.3K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

44
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$4.93M
52.6K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

42
HJ
Howe JolandaSVP, GLOBAL CONTROLLER
MIRMMirum Pharmaceuticals, Inc.
Open-market sale
SELL$86K
926 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

40
WG
Woodruff Ronald GreerEVP Safety, ESG, Maintenance
JBHTHUNT J B TRANSPORT SERVICES INC
Open-market sale
SELL$288K
1,391 sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

39
BM
Belshe MichaelDirector, CEO, President, CTO, 10% Owner
BTGOBITGO HOLDINGS, INC.
Other acquisition or disposition
J—
1.23M sh
Sep 30, 2025Jan 23, 2026
traded Sep 30, 2025
+115dSEC Form 4

Evidence

39
BM
Belshe MichaelDirector, CEO, President, CTO, 10% Owner
BTGOBITGO HOLDINGS, INC.
Other acquisition or disposition
J—
23.2K sh
Sep 30, 2025Jan 23, 2026
traded Sep 30, 2025
+115dSEC Form 4

Evidence

39
BM
Belshe MichaelDirector, CEO, President, CTO, 10% Owner
BTGOBITGO HOLDINGS, INC.
Other acquisition or disposition
J—
1.06M sh
Sep 30, 2025Jan 23, 2026
traded Sep 30, 2025
+115dSEC Form 4

Evidence

38
QJ
Quan JoanneCHIEF MEDICAL OFFICER
MIRMMirum Pharmaceuticals, Inc.
Open-market sale
SELL$170K
1,822 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

38
RP
Radovich PeterPRESIDENT AND COO
MIRMMirum Pharmaceuticals, Inc.
Open-market sale
SELL$222K
2,382 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

36
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$2.54M
27.6K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

36
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$2.39M
26.8K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence